Table 6.
Correlation Analysis of Clinical-Pathological Indices with CRC
| Sex | Age | F. nucleatum | MSI | HER-2 | CD31 | D2-40 | TNM stages | |
|---|---|---|---|---|---|---|---|---|
| Age | r=0.098 p=0.336 |
|||||||
| F. nucleatum | r=0.087 p=0.396 |
r=−0.049 p=0.630 |
||||||
| MSI | r=−0.093 p=0.364 |
r=−0.120 p=0.239 |
r=−0.013 p=0.902 |
|||||
| HER-2 | r=0.182 p=0.075 |
r=0.049 p=0.631 |
r=−0.039 p=0.701 |
r=−0.21* p=0.039 |
||||
| CD31 | r=0.051 p=0.620 |
r=0.107 p=0.297 |
r=−0.004 p=0.969 |
r=−0.187 p=0.066 |
r=0.138 p=0.175 |
|||
| D2-40 | r=0.051 p=0.620 |
r=0.107 p=0.297 |
r=−0.004 p=0.969 |
r=−0.187 p=0.066 |
r=0.138 p=0.175 |
r=1.00 p<0.001** |
||
| TNM stages | r=0.001 p=0.991 |
r=−0.005 p=0.960 |
r=−0.026 p=0.781 |
r=−0.018 p=0.851 |
r=−0.196 p=0.036* |
r=−0.252 p=0.007** |
r=−0.252 p=0.007** |
|
| Tumor Location |
r=−0.046 p=0.651 |
r=−0.186 p=0.069 |
r=−0.073 p=0.474 |
r=−0.254 p=0.013* |
r=0.115 p=0.259 |
r=0.158 p=0.121 |
r=0.158 p=0.121 |
r=−0.250 p=0.007** |
Notes: Age is divided into two levels: ≥60 and <60. *p <0.05 and **p<0.01 were considered to be statistically significant.
Abbreviations: CRC, colorectal cancer; F. nucleatum, Fusobacterium nucleatum; HER-2, human epidermal growth factor receptor-2; MSI, microsatellite instability.